Table 3.
Prevalence of SSBBGH Etiologies
| Aetiology | No. (%) |
|---|---|
| Hypertension | 30 (50%) |
| Metabolic and intoxication | 11 (18.33%) |
| Alcohol intoxication | 8 (13.33%) |
| Olanzapine intoxication | 1 (1.66%) |
| Diabetic ketoacidosis | 1 (1.66%) |
| Hyperglycemic hyperosmolar syndrome | 1 (1.66%) |
| Vascular | 10 (16.66%) |
| Lenticuostriate artery aneurysm | 2 (3.33%) |
| Hemorrhagic transformation | 3 (5%) |
| Migraine | 1 (1.66%) |
| Churg strauss syndrome | 1 (1.66%) |
| Reversible cerebral vasoconstriction syndrome | 1 (1.66%) |
| Cerebral vein thrombosis | 1 (1.66%) |
| COL4A1 mutation | 1 (1.66%) |
| Infection | 6 (10%) |
| Covid-19-related encephalitis | 1 (1.66%) |
| Toxoplasmosis encephalitis | 2 (3.33%) |
| Dengue Encephalitis | 1 (1.66%) |
| Mucormycosis-caused encephalitis | 1 (1.66%) |
| Japanese encephalitis | 1 (1.66%) |
| Unknown | 2 (3.33%) |
Abbreviation: COL4A1, Collagen Type IV Alpha 1.